Zobrazeno 1 - 10
of 13
pro vyhledávání: '"T. I. Korotenko"'
Autor:
T. I. Korotenko, Vitaly Ya. Gorbatyuk, Yu. E. Shapiro, Sergei A. Andronati, Mazurov Anatoly A
Publikováno v:
International Journal of Peptide and Protein Research. 42:14-19
Formation of by-products pyroglutamylglutamine diketopiperazine (5a) or pyroglutamylasparagine diketopiperazine (5b) were observed during the condensation of pyroglutamic acid active ester with C-protected glutaminyl(or asparaginyl)-proline derivativ
Autor:
S. A. Andronati, T. I. Korotenko, T. A. Voronina, A. A. Mazurov, N. I. Sokolenko, Yu. E. Shapiro, A. I. Dyadenko, V. Ya. Gorbatyuk
Publikováno v:
ChemInform. 28
Autor:
Yu. E. Shapiro, A. V. Mazepa, T. I. Korotenko, Sergei A. Andronati, Mazurov Anatoly A, V. Ya. Gorbatyuk, A. I. Dyadenko
Publikováno v:
ChemInform. 30
Autor:
Vitalii Ya. Gorbatyuk, Sergei A. Andronati, Mazurov Anatoly A, Alexei I. Dyadenko, T. A. Voronina, Nikolai I. Sokolenko, Yu. E. Shapiro, T. I. Korotenko
Publikováno v:
Bioorganicmedicinal chemistry. 5(11)
For the purpose of rational modification of the TRH molecule, we were pursuing an approach that consists of two steps: (1) ‘obligatory’ replacement of histidine with glutamine in TRH and (2) the application of conformational constraints for putat
Autor:
V Ia, Gorbatiuk, Iu E, Shapiro, A A, Mazurov, V G, Zhuravlev, S A, Andronati, T I, Korotenko, P Ia, Romanovskiĭ
Publikováno v:
Bioorganicheskaia khimiia. 18(2)
Preferable conformations of thyrotropin-releasing hormone (TRH, Glp-His-Pro-NH2) and its analogues Glp-Glu(R)-Pro-NH2 (R = NHCH(CH3)CH2Ar), Glp-Gln-Abu-NH2, Dho-Gln-Abu-NH2 in DMSO solution are determined using two-dimensional 1H NMR spectroscopy (de
Autor:
E. K. Georgianova, A. N. Petrov, S. A. Andronati, Mazurov Anatoly A, T. I. Korotenko, A. F. Galatin
Publikováno v:
Pharmaceutical Chemistry Journal. 21:760-764
Autor:
Yu. A. Simonov, T. A. Voronina, T. A. Shibanova, S. A. Andronati, T. I. Korotenko, A. A. Dvorkin
Publikováno v:
Chemistry of Heterocyclic Compounds. 18:755-758
5-Methyl-1,2-dihydro-3H-1,4-benzodiazepin-2-one, which is an antagonist of 5-aryl-1,2-dihydro-3H-1,4-benzodiazepin-2-ones, was subjected to a complete x-ray diffraction study. The crystals have monoclinic syngony witha = 11.456(5), b = 8.195(3), c =
Publikováno v:
Pharmaceutical Chemistry Journal. 22:106-110
Publikováno v:
Pharmaceutical Chemistry Journal. 17:769-772
Publikováno v:
Pharmaceutical Chemistry Journal. 23:562-567